
Proposal for the Public Procurement Act, adoption of a new pharmaceutical legislation, and revision of pharmacovigilance practices should improve patient access to safe and innovative medicines in Europe.
FDA's revised guidance on 21 CFR Part 11 offers relief to the regulated industry by providing for enforcement discretion and suggesting a risk-based approach to compliance.
about 23 years ago
Improving the Management of Batch Recordsabout 23 years ago
Understanding Data, Symbol, and Technology Optionsabout 23 years ago
Web Services in Pharmaceutical Manufacturingabout 23 years ago
Integrated Compliance Management





